National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:2ccbcc09e539e977eda2ab7c3b090305]
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome [clinicaltrials:NCT00001145]Treatment of Wegener's Granulomatosis With Cyclophosphamide [clinicaltrials:NCT00001155]Clinical Investigation of Infections Due to Leishmanial Parasites [clinicaltrials:NCT00001169]Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization [clinicaltrials:NCT00001173]Effects of HIV on the Development and Function of Bone Marrow Cells [clinicaltrials:NCT00001243]Steroids and Methotrexate to Treat Systemic Vasculitis [clinicaltrials:NCT00001256]Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease [clinicaltrials:NCT00001280]A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients [clinicaltrials:NCT00001282]A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood [clinicaltrials:NCT00001317]Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [clinicaltrials:NCT00001318]Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts [clinicaltrials:NCT00001319]Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs [clinicaltrials:NCT00001353]Interleukin-2 Therapy for HIV Infection - Supplemental Procedures [clinicaltrials:NCT00001354]Characteristics of Mast Cells in Mastocytosis [clinicaltrials:NCT00001356]Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients [clinicaltrials:NCT00001357]Interferon Gamma for Drug Resistant Tuberculosis [clinicaltrials:NCT00001407]Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications [clinicaltrials:NCT00001409]Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides [clinicaltrials:NCT00001473]Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients [clinicaltrials:NCT00001474]Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist [clinicaltrials:NCT00001475]Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy [clinicaltrials:NCT00001477]Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers [clinicaltrials:NCT00001538]The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo [clinicaltrials:NCT00001540]Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis [clinicaltrials:NCT00001541]Fluconazole Prophylaxis of Thrush in AIDS [clinicaltrials:NCT00001542]Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis [clinicaltrials:NCT00001646]White Blood Cell Infusions to Treat HIV Infection [clinicaltrials:NCT00001647]Valaciclovir to Prevent Transmission of Herpes Simplex Virus [clinicaltrials:NCT00001649]An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections [clinicaltrials:NCT00001757]Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz [clinicaltrials:NCT00001758]Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography [clinicaltrials:NCT00001759]Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals [clinicaltrials:NCT00001760]Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis [clinicaltrials:NCT00001761]Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection [clinicaltrials:NCT00001763]Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions [clinicaltrials:NCT00001764]Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease [clinicaltrials:NCT00001765]Drug Interactions Among Anti-HIV Agents [clinicaltrials:NCT00001766]Etanercept to Treat Wegener's Granulomatosis [clinicaltrials:NCT00001901]Prevention of RSV Infections in Bone Marrow Transplant Recipients [clinicaltrials:NCT00001903]Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness [clinicaltrials:NCT00001904]
location [clinicaltrials_vocabulary:location]
National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:2ccbcc09e539e977eda2ab7c3b090305]
Bio2RDF identifier
2ccbcc09e539e977eda2ab7c3b090305
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2ccbcc09e539e977eda2ab7c3b090305
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:2ccbcc09e539e977eda2ab7c3b090305
title
National Institute of Allergy and Infectious Diseases (NIAID)
@en
type
label
National Institute of Allergy ...... bcc09e539e977eda2ab7c3b090305]
@en